Sanit Bahri is the founder and CEO of a medical tourism company based in Bombay, India called Medsurge Healthcare Consultants. Basically, they are inclined to providing quality medical assistance to patients overseas who are seeking treatment options in India. Sanit is a very experienced Medical Tourism Consultant, wherein, he has helped a total of 901 patients over the last four years. In this episode, he shared about a 13-year old Nigerian girl who had to undergo a liver resection. The father of the child has intended to bring his daughter to India but due to poverty, he admitted her daughter into a local teaching hospital in Lagos, Nigeria instead. The patient was in oxygen support and her condition has aggravated. In order for them to proceed with the treatment and travel to India, the father had to loan money for their finances. Find out more of how Sanit and his company have helped the patient and the success of the treatment thereafter.
Thank you for listening. We would appreciate your comments and reviews.
In This Episode, You’ll Learn
- About Sanit Bahri’s medical tourism company in India
- How Sanit assisted a 13-year old Nigerian girl to get her needed treatment in India
- About the success story of the Nigerian patient after her treatment
- How much the surgeries, the patient had undergone, costed
- About the Typical Questions an International patient should ask when considering to travel overseas to receive treatments
- About the after-care treatments the patient receives after a certain procedure
- About the packages Sanit is offering to patients and its inclusions
- Sanit Bahri’s LinkedIn account
- Sanit’s blog
- Medsurge India Website
- Medsurge Healthcare Consultants Facebook page
- Readyforchange.com – mentioned in the episode – a company that helps patients get surgery in India.
- Contact info: email@example.com
The Onwards Medical Breakthrough
“Sometimes the best solutions are the simplest ones. This is the philosophy that Northeastern professor Vladimir Torchilin and his team took in new research carried out in collaboration with physics professor Dmitri Lapotko from Rice University and presented in a paper published Sunday in the journal Nature Medicine.”
“You start with two very well known and simple things,” Torchilin said. “Nanomedicines and nanoparticles.” Both allow clinicians to steer materials to specific cells in the body using recognition factors that are disproportionately expressed on cancer cells. In the case of drug-loaded tumor-targeted nanomedicines, cancer cells welcome much higher concentrations of drug molecules. In the case of nanoparticles, it’s tiny tumor-targeted crumbs of gold that end up inside the tumor cells.”
You can learn more about this discovery at this link.